Clinical Trial

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Study acronym: MODIUS
Recruiting
View on ClinicalTrials.gov →
Summary
A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type 2 diabetes (T2D) who use MDI, basal insulin only, or who are candidates to initiate basal insulin, in conjunction with continuous glucose monitoring (CGM).
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-30
notable Enrollment increased: 36 -> 102 participants 2026-05-30
Trial Details
NCT Number NCT07599982
Lead Sponsor DreaMed Diabetes
Collaborators: Jaeb Center for Health Research, Abbott Diabetes Care
Conditions Type 1 Diabetes (T1D), Type 2 Diabetes (T2D)
Enrollment 102 participants
Start Date 2026-05-25
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22